Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
Publications
Publications
  • April 2018
  • Supplement
  • HBS Case Collection

Celgene

By: Malcolm Baker and Emily R. McComb
  • Format:Electronic
  • | Language:English
ShareBar

Abstract

In February 2011, Adam Koppel, a Managing Director at Brookside Capital, the public equity arm of Bain Capital, must decide whether to increase or exit the firm’s position in Celgene Corporation. News has emerged that raises potential safety concerns associated with Celgene’s key drug, Revlimid. In response, Celgene’s share price has traded down 20% in the last two months, and is now almost 10% below the level where Brookside made their initial investment.

Keywords

Life Sciences; Biotechnology; Public Market Investing; Celgene; Revlimid; Hedge Fund; Growth Stocks; Valuation; Investment; Decision Choices and Conditions; Analysis

Citation

Baker, Malcolm, and Emily R. McComb. "Celgene." Harvard Business School Spreadsheet Supplement 218-743, April 2018.
  • Purchase

About The Authors

Malcolm P. Baker

Finance
→More Publications

Emily R. McComb

Finance
→More Publications

More from the Authors

    • March 2021
    • Faculty Research

    Carnival Corp: Cruising In the Time of Covid

    By: Emily R. McComb and Erik Stafford
    • October 2020 (Revised December 2020)
    • Faculty Research

    Investing at Pivotal Ventures

    By: Emil N. Siriwardane, Emily R. McComb and Eren Kuzucu
    • August 2020
    • Journal of Financial and Quantitative Analysis

    Leverage and the Beta Anomaly

    By: Malcolm Baker, Mathias F. Hoeyer and Jeffrey Wurgler
More from the Authors
  • Carnival Corp: Cruising In the Time of Covid By: Emily R. McComb and Erik Stafford
  • Investing at Pivotal Ventures By: Emil N. Siriwardane, Emily R. McComb and Eren Kuzucu
  • Leverage and the Beta Anomaly By: Malcolm Baker, Mathias F. Hoeyer and Jeffrey Wurgler
ǁ
Campus Map
Harvard Business School
Soldiers Field
Boston, MA 02163
→Map & Directions
→More Contact Information
  • Make a Gift
  • Site Map
  • Jobs
  • Harvard University
  • Trademarks
  • Policies
  • Digital Accessibility
Copyright © President & Fellows of Harvard College